Which information is essential for regulatory review of investigational products?

• A. Marketing materials.
• B. Travel arrangements for investigators.
• C. Safety, efficacy, and manufacturing details.
• D. Employee benefits.

Answer: (C)

Regulatory review focuses on information about safety, efficacy, and manufacturing quality of the investigational product. Regulators need comprehensive safety data (including adverse events and risk management) to weigh potential benefits against risks, early efficacy signals to gauge potential clinical benefit, and detailed manufacturing information (CMC data, quality controls, stability, and facilities) to ensure the product can be produced consistently and safely. Marketing materials, travel plans for investigators, and employee benefits do not impact the assessment of safety, efficacy, or product quality and are not central to the regulatory evaluation of the investigational product.